Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Mar 15;99(6):1351–1360. doi: 10.1172/JCI119294

The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39.

A J Marcus 1, M J Broekman 1, J H Drosopoulos 1, N Islam 1, T N Alyonycheva 1, L B Safier 1, K A Hajjar 1, D N Posnett 1, M A Schoenborn 1, K A Schooley 1, R B Gayle 1, C R Maliszewski 1
PMCID: PMC507951  PMID: 9077545

Abstract

We previously demonstrated that when platelets are in motion and in proximity to endothelial cells, they become unresponsive to agonists (Marcus, A.J., L.B. Safier, K.A. Hajjar, H.L. Ullman, N. Islam, M.J. Broekman, and A.M. Eiroa. 1991. J. Clin. Invest. 88:1690-1696). This inhibition is due to an ecto-ADPase on the surface of endothelial cells which metabolizes ADP released from activated platelets, resulting in blockade of the aggregation response. Human umbilical vein endothelial cells (HUVEC) ADPase was biochemically classified as an E-type ATP-diphosphohydrolase. The endothelial ecto-ADPase is herein identified as CD39, a molecule originally characterized as a lymphoid surface antigen. All HUVEC ecto-ADPase activity was immunoprecipitated by monoclonal antibodies to CD39. Surface localization of HUVEC CD39 was established by confocal microscopy and flow cytometric analyses. Transfection of COS cells with human CD39 resulted in both ecto-ADPase activity as well as surface expression of CD39. PCR analyses of cDNA obtained from HUVEC mRNA and recombinant human CD39 revealed products of the same size, and of identical sequence. Northern blot analyses demonstrated that HUVEC express the same sized transcripts for CD39 as MP-1 cells (from which CD39 was originally cloned). We established the role of CD39 as a prime endothelial thromboregulator by demonstrating that CD39-transfected COS cells acquired the ability to inhibit ADP-induced aggregation in platelet-rich plasma. The identification of HUVEC ADPase/CD39 as a constitutively expressed potent inhibitor of platelet reactivity offers new prospects for antithrombotic therapeusis.

Full Text

The Full Text of this article is available as a PDF (362.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Battastini A. M., Oliveira E. M., Moreira C. M., Bonan C. D., Sarkis J. J., Dias R. D. Solubilization and characterization of an ATP diphosphohydrolase (EC 3.6.1.5) from rat brain synaptic plasma membranes. Biochem Mol Biol Int. 1995 Oct;37(2):209–219. [PubMed] [Google Scholar]
  2. Broekman M. J., Eiroa A. M., Marcus A. J. Inhibition of human platelet reactivity by endothelium-derived relaxing factor from human umbilical vein endothelial cells in suspension: blockade of aggregation and secretion by an aspirin-insensitive mechanism. Blood. 1991 Aug 15;78(4):1033–1040. [PubMed] [Google Scholar]
  3. Collins T., Korman A. J., Wake C. T., Boss J. M., Kappes D. J., Fiers W., Ault K. A., Gimbrone M. A., Jr, Strominger J. L., Pober J. S. Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc Natl Acad Sci U S A. 1984 Aug;81(15):4917–4921. doi: 10.1073/pnas.81.15.4917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Côté Y. P., Filep J. G., Battistini B., Gauvreau J., Sirois P., Beaudoin A. R. Characterization of ATP-diphosphohydrolase activities in the intima and media of the bovine aorta: evidence for a regulatory role in platelet activation in vitro. Biochim Biophys Acta. 1992 Jun 9;1139(1-2):133–142. doi: 10.1016/0925-4439(92)90092-2. [DOI] [PubMed] [Google Scholar]
  5. Dombrowski K. E., Ke Y., Thompson L. F., Kapp J. A. Antigen recognition by CTL is dependent upon ectoATPase activity. J Immunol. 1995 Jun 15;154(12):6227–6237. [PubMed] [Google Scholar]
  6. Handa M., Guidotti G. Purification and cloning of a soluble ATP-diphosphohydrolase (apyrase) from potato tubers (Solanum tuberosum). Biochem Biophys Res Commun. 1996 Jan 26;218(3):916–923. doi: 10.1006/bbrc.1996.0162. [DOI] [PubMed] [Google Scholar]
  7. Kansas G. S., Wood G. S., Tedder T. F. Expression, distribution, and biochemistry of human CD39. Role in activation-associated homotypic adhesion of lymphocytes. J Immunol. 1991 Apr 1;146(7):2235–2244. [PubMed] [Google Scholar]
  8. Lyman S. D., James L., Johnson L., Brasel K., de Vries P., Escobar S. S., Downey H., Splett R. R., Beckmann M. P., McKenna H. J. Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells. Blood. 1994 May 15;83(10):2795–2801. [PubMed] [Google Scholar]
  9. Maliszewski C. R., Delespesse G. J., Schoenborn M. A., Armitage R. J., Fanslow W. C., Nakajima T., Baker E., Sutherland G. R., Poindexter K., Birks C. The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization. J Immunol. 1994 Oct 15;153(8):3574–3583. [PubMed] [Google Scholar]
  10. Marcus A. J., Broekman M. J. Cell-free hemoglobin as an oxygen carrier removes nitric oxide, resulting in defective thromboregulation. Circulation. 1996 Jan 15;93(2):208–209. doi: 10.1161/01.cir.93.2.208. [DOI] [PubMed] [Google Scholar]
  11. Marcus A. J. Eicosanoid interactions between platelets, endothelial cells, and neutrophils. Methods Enzymol. 1990;187:585–599. doi: 10.1016/0076-6879(90)87066-c. [DOI] [PubMed] [Google Scholar]
  12. Marcus A. J., Safier L. B., Broekman M. J., Islam N., Fliessbach J. H., Hajjar K. A., Kaminski W. E., Jendraschak E., Silverstein R. L., von Schacky C. Thrombosis and inflammation as multicellular processes: significance of cell-cell interactions. Thromb Haemost. 1995 Jul;74(1):213–217. [PubMed] [Google Scholar]
  13. Marcus A. J., Safier L. B., Hajjar K. A., Ullman H. L., Islam N., Broekman M. J., Eiroa A. M. Inhibition of platelet function by an aspirin-insensitive endothelial cell ADPase. Thromboregulation by endothelial cells. J Clin Invest. 1991 Nov;88(5):1690–1696. doi: 10.1172/JCI115485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Marcus A. J., Safier L. B., Ullman H. L., Islam N., Broekman M. J., Falck J. R., Fischer S., von Schacky C. Platelet-neutrophil interactions. (12S)-hydroxyeicosatetraen-1,20-dioic acid: a new eicosanoid synthesized by unstimulated neutrophils from (12S)-20-dihydroxyeicosatetraenoic acid. J Biol Chem. 1988 Feb 15;263(5):2223–2229. [PubMed] [Google Scholar]
  15. Marcus A. J., Safier L. B., Ullman H. L., Islam N., Broekman M. J., von Schacky C. Studies on the mechanism of omega-hydroxylation of platelet 12-hydroxyeicosatetraenoic acid (12-HETE) by unstimulated neutrophils. J Clin Invest. 1987 Jan;79(1):179–187. doi: 10.1172/JCI112781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Marcus A. J., Weksler B. B., Jaffe E. A., Broekman M. J. Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells. J Clin Invest. 1980 Nov;66(5):979–986. doi: 10.1172/JCI109967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Meghji P., Pearson J. D., Slakey L. L. Kinetics of extracellular ATP hydrolysis by microvascular endothelial cells from rat heart. Biochem J. 1995 Jun 15;308(Pt 3):725–731. doi: 10.1042/bj3080725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Olsen S. B., Tang D. B., Jackson M. R., Gomez E. R., Ayala B., Alving B. M. Enhancement of platelet deposition by cross-linked hemoglobin in a rat carotid endarterectomy model. Circulation. 1996 Jan 15;93(2):327–332. doi: 10.1161/01.cir.93.2.327. [DOI] [PubMed] [Google Scholar]
  19. Plesner L. Ecto-ATPases: identities and functions. Int Rev Cytol. 1995;158:141–214. doi: 10.1016/s0074-7696(08)62487-0. [DOI] [PubMed] [Google Scholar]
  20. Posnett D. N., Marboe C. C., Knowles D. M., 2nd, Jaffe E. A., Kunkel H. G. A membrane antigen (HC1) selectively present on hairy cell leukemia cells, endothelial cells, and epidermal basal cells. J Immunol. 1984 Jun;132(6):2700–2702. [PubMed] [Google Scholar]
  21. Rowe M., Hildreth J. E., Rickinson A. B., Epstein M. A. Monoclonal antibodies to Epstein-Barr virus-induced, transformation-associated cell surface antigens: binding patterns and effect upon virus-specific T-cell cytotoxicity. Int J Cancer. 1982 Apr 15;29(4):373–381. doi: 10.1002/ijc.2910290403. [DOI] [PubMed] [Google Scholar]
  22. Stout J. G., Strobel R. S., Kirley T. L. Properties of and proteins associated with the extracellular ATPase of chicken gizzard smooth muscle. A monoclonal antibody study. J Biol Chem. 1995 May 19;270(20):11845–11850. doi: 10.1074/jbc.270.20.11845. [DOI] [PubMed] [Google Scholar]
  23. Strobel R. S., Nagy A. K., Knowles A. F., Buegel J., Rosenberg M. D. Chicken oviductal ecto-ATP-diphosphohydrolase. Purification and characterization. J Biol Chem. 1996 Jul 5;271(27):16323–16331. doi: 10.1074/jbc.271.27.16323. [DOI] [PubMed] [Google Scholar]
  24. Vasconcelos E. G., Ferreira S. T., Carvalho T. M., Souza W., Kettlun A. M., Mancilla M., Valenzuela M. A., Verjovski-Almeida S. Partial purification and immunohistochemical localization of ATP diphosphohydrolase from Schistosoma mansoni. Immunological cross-reactivities with potato apyrase and Toxoplasma gondii nucleoside triphosphate hydrolase. J Biol Chem. 1996 Sep 6;271(36):22139–22145. doi: 10.1074/jbc.271.36.22139. [DOI] [PubMed] [Google Scholar]
  25. Wang T. F., Guidotti G. CD39 is an ecto-(Ca2+,Mg2+)-apyrase. J Biol Chem. 1996 Apr 26;271(17):9898–9901. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES